Overview
Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
Status:
Completed
Completed
Trial end date:
2005-06-01
2005-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine the safety and IOP-lowering ability of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertensionPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Alcon ResearchTreatments:
Travoprost
Criteria
Inclusion Criteria:- Adult subjects of either sex and any race 18 years or older with open-angle glaucoma
or ocular hypertension. Patients with logMAR visual acuity not worse than 0.6 in
either eye or any clinically relevant ophthalmic/systemic condition will be excluded.
Exclusion Criteria:
- See Inclusion Criteria